Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Share a link:
https://casecent.re/p/21961
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is the first of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes US-based Amgen. During the period 1998-1999, the company focused research chiefly on genomics, cancer, and neuro-science. The principal therapeutic areas were hematopoiesis (blood cell production), autoimmunity, neuroendocrinology, and soft-tissue repair. The case offers a summary of product development and marketing in these key areas. Revenue and balance sheet information also provided. One in a series of eight cases drawn from public information sources. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources
About
Abstract
This is the first of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes US-based Amgen. During the period 1998-1999, the company focused research chiefly on genomics, cancer, and neuro-science. The principal therapeutic areas were hematopoiesis (blood cell production), autoimmunity, neuroendocrinology, and soft-tissue repair. The case offers a summary of product development and marketing in these key areas. Revenue and balance sheet information also provided. One in a series of eight cases drawn from public information sources. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
Settings
Related
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources